Carol Wilkinson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Child Language | 1 | 2021 | 63 | 0.760 |
Why?
|
Electroencephalography | 5 | 2023 | 6133 | 0.710 |
Why?
|
Fragile X Syndrome | 1 | 2021 | 116 | 0.700 |
Why?
|
Language Development | 2 | 2021 | 187 | 0.670 |
Why?
|
Observation | 1 | 2019 | 312 | 0.610 |
Why?
|
Checklist | 1 | 2019 | 817 | 0.420 |
Why?
|
Cytoskeletal Proteins | 4 | 2013 | 1369 | 0.400 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1445 | 0.380 |
Why?
|
Child Development | 1 | 2019 | 2213 | 0.310 |
Why?
|
Brain | 5 | 2023 | 26345 | 0.290 |
Why?
|
Cognition | 2 | 2023 | 6686 | 0.280 |
Why?
|
Receptors, AMPA | 3 | 2013 | 329 | 0.260 |
Why?
|
Nerve Tissue Proteins | 4 | 2013 | 4463 | 0.240 |
Why?
|
Pediatrics | 1 | 2019 | 3454 | 0.240 |
Why?
|
Autistic Disorder | 2 | 2021 | 1164 | 0.210 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 118 | 0.180 |
Why?
|
Neuronal Plasticity | 4 | 2013 | 1416 | 0.180 |
Why?
|
Event-Related Potentials, P300 | 1 | 2021 | 150 | 0.180 |
Why?
|
Serum Response Factor | 1 | 2009 | 81 | 0.170 |
Why?
|
Infant | 7 | 2023 | 34923 | 0.140 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 453 | 0.140 |
Why?
|
Child, Preschool | 5 | 2023 | 40802 | 0.130 |
Why?
|
RNA Stability | 1 | 2007 | 321 | 0.130 |
Why?
|
Language Development Disorders | 1 | 2016 | 196 | 0.120 |
Why?
|
Siblings | 1 | 2019 | 853 | 0.120 |
Why?
|
Income | 1 | 2023 | 1877 | 0.120 |
Why?
|
Mothers | 1 | 2023 | 2143 | 0.110 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1146 | 0.110 |
Why?
|
Synapses | 1 | 2010 | 1719 | 0.100 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7726 | 0.090 |
Why?
|
Program Evaluation | 1 | 2016 | 2484 | 0.080 |
Why?
|
Parents | 2 | 2021 | 3368 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9684 | 0.070 |
Why?
|
Child | 4 | 2023 | 77033 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3636 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10398 | 0.060 |
Why?
|
Bicuculline | 2 | 2013 | 99 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7690 | 0.060 |
Why?
|
Health Promotion | 1 | 2016 | 2187 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2013 | 2965 | 0.060 |
Why?
|
Neurons | 3 | 2013 | 9336 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13880 | 0.060 |
Why?
|
Gene Expression | 1 | 2006 | 7788 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12049 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2007 | 13002 | 0.050 |
Why?
|
Homeostasis | 1 | 2013 | 3348 | 0.050 |
Why?
|
Humans | 11 | 2023 | 739398 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 53037 | 0.050 |
Why?
|
Neuropeptide Y | 1 | 2010 | 200 | 0.040 |
Why?
|
Telemedicine | 1 | 2016 | 2844 | 0.040 |
Why?
|
Transcription Factors | 1 | 2009 | 12120 | 0.040 |
Why?
|
PC12 Cells | 1 | 2009 | 330 | 0.040 |
Why?
|
AIDS-Related Complex | 1 | 2007 | 111 | 0.040 |
Why?
|
San Francisco | 1 | 2016 | 159 | 0.040 |
Why?
|
Male | 5 | 2023 | 349022 | 0.030 |
Why?
|
GABA Antagonists | 1 | 2006 | 128 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2022 | 1057 | 0.030 |
Why?
|
Rats | 3 | 2013 | 24270 | 0.030 |
Why?
|
Blotting, Northern | 1 | 2006 | 1583 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2006 | 449 | 0.030 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2013 | 62 | 0.030 |
Why?
|
Nuclear Localization Signals | 1 | 2013 | 80 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2013 | 387 | 0.030 |
Why?
|
Language | 1 | 2021 | 1447 | 0.030 |
Why?
|
Tetrodotoxin | 1 | 2013 | 260 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 2013 | 572 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2006 | 1934 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2006 | 604 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2013 | 374 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2009 | 19220 | 0.030 |
Why?
|
Drug Interactions | 1 | 2006 | 1456 | 0.020 |
Why?
|
Memory | 1 | 2010 | 2161 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2006 | 2732 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2013 | 576 | 0.020 |
Why?
|
Animals | 5 | 2013 | 168368 | 0.020 |
Why?
|
Blotting, Western | 1 | 2006 | 5181 | 0.020 |
Why?
|
Transfection | 1 | 2006 | 5884 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3722 | 0.020 |
Why?
|
Female | 3 | 2023 | 378853 | 0.020 |
Why?
|
Base Sequence | 1 | 2009 | 12804 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1991 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1698 | 0.020 |
Why?
|
Models, Molecular | 1 | 2007 | 5460 | 0.020 |
Why?
|
Mice | 3 | 2013 | 81002 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 18125 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2010 | 14558 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3802 | 0.020 |
Why?
|
Pilot Projects | 1 | 2016 | 8275 | 0.010 |
Why?
|
Calcium | 1 | 2006 | 5742 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11347 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 62693 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29002 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9734 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 40389 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17384 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5721 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7862 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 21863 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 29658 | 0.010 |
Why?
|
Adult | 1 | 2016 | 213394 | 0.000 |
Why?
|